Alliance Wealth Advisors, LLC /Ut Halozyme Therapeutics, Inc. Transaction History
Alliance Wealth Advisors, LLC /Ut
- $335 Billion
- Q1 2024
A detailed history of Alliance Wealth Advisors, LLC /Ut transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Alliance Wealth Advisors, LLC /Ut holds 12,315 shares of HALO stock, worth $640,503. This represents 0.15% of its overall portfolio holdings.
Number of Shares
12,315
Previous 9,610
28.15%
Holding current value
$640,503
Previous $355 Million
41.05%
% of portfolio
0.15%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$949 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$679 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$337 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$214 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$197 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.24B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...